PubMed

Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors.

Sugimoto H, Grahovac G, Zeisberg M, Kalluri R.

Diabetes. 2007 Jul;56(7):1825-33. Epub 2007 Apr 24.PMID: 17456853 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.

Wang S, Chen Q, Simon TC, Strebeck F, Chaudhary L, Morrissey J, Liapis H, Klahr S, Hruska KA.

Kidney Int. 2003 Jun;63(6):2037-49.PMID: 12753291 [PubMed - indexed for MEDLINE]Related articles

New potential agents in treating diabetic kidney disease: the fourth act.

Williams ME.

Drugs. 2006;66(18):2287-98. Review.PMID: 17181372 [PubMed - indexed for MEDLINE]Related articles

Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropathy in B6 db/db mice.

Zheng F, Zeng YJ, Plati AR, Elliot SJ, Berho M, Potier M, Striker LJ, Striker GE.

Kidney Int. 2006 Aug;70(3):507-14. Epub 2006 Jun 14.PMID: 16775596 [PubMed - indexed for MEDLINE]Related articles

Renal bone morphogenetic protein-7 protects against diabetic nephropathy.

Wang S, de Caestecker M, Kopp J, Mitu G, Lapage J, Hirschberg R.

J Am Soc Nephrol. 2006 Sep;17(9):2504-12. Epub 2006 Aug 9.PMID: 16899516 [PubMed - indexed for MEDLINE]Related articlesFree article

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

J Am Soc Nephrol. 2004 Aug;15(8):2125-38.PMID: 15284298 [PubMed - indexed for MEDLINE]Related articlesFree article

The next generation of diabetic nephropathy therapies: an update.

Williams ME, Tuttle KR.

Adv Chronic Kidney Dis. 2005 Apr;12(2):212-22. Review.PMID: 15822057 [PubMed - indexed for MEDLINE]Related articles

Can advanced glycation end product inhibitors modulate more than one pathway to enhance renoprotection in diabetes?

Coughlan MT, Cooper ME, Forbes JM.

Ann N Y Acad Sci. 2005 Jun;1043:750-8. Review.PMID: 16037302 [PubMed - indexed for MEDLINE]Related articles

N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.

Schwedler SB, Verbeke P, Bakala H, Weiss MF, Vilar J, Depreux P, Fourmaintraux E, Striker LJ, Striker GE.

Diabetes Obes Metab. 2001 Aug;3(4):230-9.PMID: 11520302 [PubMed - indexed for MEDLINE]Related articles

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Müller GA, Kalluri R.

Am J Physiol Renal Physiol. 2003 Dec;285(6):F1060-7. Epub 2003 Aug 12.PMID: 12915382 [PubMed - indexed for MEDLINE]Related articlesFree article

Pimagedine: a novel therapy for diabetic nephropathy.

Abdel-Rahman E, Bolton WK.

Expert Opin Investig Drugs. 2002 Apr;11(4):565-74. Review.PMID: 11922864 [PubMed - indexed for MEDLINE]Related articles

Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.

Williams ME.

Curr Diab Rep. 2004 Dec;4(6):441-6. Review.PMID: 15539009 [PubMed - indexed for MEDLINE]Related articles

From molecular footprints of disease to new therapeutic interventions in diabetic nephropathy.

Miyata T, Yamamoto M, Izuhara Y.

Ann N Y Acad Sci. 2005 Jun;1043:740-9.PMID: 16037301 [PubMed - indexed for MEDLINE]Related articles

LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats.

Figarola JL, Scott S, Loera S, Tessler C, Chu P, Weiss L, Hardy J, Rahbar S.

Diabetologia. 2003 Aug;46(8):1140-52. Epub 2003 Jul 5.PMID: 12845431 [PubMed - indexed for MEDLINE]Related articles

The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function.

Klahr S.

J Nephrol. 2003 Mar-Apr;16(2):179-85. Review.PMID: 12768064 [PubMed - indexed for MEDLINE]Related articles

Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor.

Klahr S, Morrissey J.

Kidney Int Suppl. 2003 Nov;(87):S105-12. Review.PMID: 14531782 [PubMed - indexed for MEDLINE]Related articles

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

Degenhardt TP, Alderson NL, Arrington DD, Beattie RJ, Basgen JM, Steffes MW, Thorpe SR, Baynes JW.

Kidney Int. 2002 Mar;61(3):939-50.PMID: 11849448 [PubMed - indexed for MEDLINE]Related articlesFree article

Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy.

Ohashi S, Abe H, Takahashi T, Yamamoto Y, Takeuchi M, Arai H, Nagata K, Kita T, Okamoto H, Yamamoto H, Doi T.

J Biol Chem. 2004 May 7;279(19):19816-23. Epub 2004 Mar 5.PMID: 15004023 [PubMed - indexed for MEDLINE]Related articlesFree article

Tubular atrophy, interstitial fibrosis, and inflammation in type 2 diabetic db/db mice. An accelerated model of advanced diabetic nephropathy.

Ninichuk V, Kulkarni O, Clauss S, Anders HJ.

Eur J Med Res. 2007 Aug 16;12(8):351-5.PMID: 17933712 [PubMed - indexed for MEDLINE]Related articles

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy.

Adhikary L, Chow F, Nikolic-Paterson DJ, Stambe C, Dowling J, Atkins RC, Tesch GH.

Diabetologia. 2004 Jul;47(7):1210-22. Epub 2004 Jul 1.PMID: 15232685 [PubMed - indexed for MEDLINE]Related articles